How big is the Non-steroidal Anti-Inflammatory Drugs Market?

The Non-steroidal Anti-Inflammatory Drugs Market size is expected to reach USD 26.83 billion in 2024 and grow at a CAGR of 7.89% to reach USD 39.22 billion by 2029. Read More

What is the current Non-steroidal Anti-Inflammatory Drugs Market size?

In 2024, the Non-steroidal Anti-Inflammatory Drugs Market size is expected to reach USD 26.83 billion. Read More

Who are the key players in Non-steroidal Anti-Inflammatory Drugs Market?

Pfizer Inc., Johnson & Johnson, Bayer AG, Sanofi S.A. and Haleon plc are the major companies operating in the Non-steroidal Anti-Inflammatory Drugs Market. Read More

Which is the fastest growing region in Non-steroidal Anti-Inflammatory Drugs Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Non-steroidal Anti-Inflammatory Drugs Market?

In 2024, the North America accounts for the largest market share in Non-steroidal Anti-Inflammatory Drugs Market. Read More

What years does this Non-steroidal Anti-Inflammatory Drugs Market cover, and what was the market size in 2023?

In 2023, the Non-steroidal Anti-Inflammatory Drugs Market size was estimated at USD 24.71 billion. The report covers the Non-steroidal Anti-Inflammatory Drugs Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Non-steroidal Anti-Inflammatory Drugs Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share

Statistics for the 2023 & 2024 Non-steroidal Anti-Inflammatory Drugs (NSAIDs) market share, created by Mordor Intelligence™ Industry Reports. Non-steroidal Anti-Inflammatory Drugs (NSAIDs) share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Industry

The non-steroidal anti-inflammatory drugs (NSAIDs) market is fragmented, with several players around the globe. In terms of market share, few of the major players now dominate the market. With the increase in research and development activity, many regional players are expected to contribute to the NSAIDs market during the forecast period. Some of the key players in the market are Pfizer Inc., Haleon PLC, Johnson & Johnson, Bayer AG, Sanofi SA, Horizon Therapeutics PLC, Sun Pharmaceutical Industries Ltd, and Reckitt Benckiser Group PLC.